Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome.
about
The role of hyperosmotic stress in inflammation and diseaseSplenic leukocytes mediate the hyperglycemic exacerbation of myocardial infarct size in mice.Acute hyperglycemia abolishes ischemic preconditioning by inhibiting Akt phosphorylation: normalizing blood glucose before ischemia restores ischemic preconditioning.Acute hyperglycemia enhances oxidative stress and exacerbates myocardial infarction by activating nicotinamide adenine dinucleotide phosphate oxidase during reperfusion.Intensive insulin therapy and mortality in critically ill patients.Influence on prognosis and prevalence of stress hyperglycemia in a cohort of patients with acute coronary syndrome.Prognostic value of admission blood glucose level in patients with and without diabetes mellitus who sustain ST segment elevation myocardial infarction complicated by cardiogenic shock.EphA2-receptor deficiency exacerbates myocardial infarction and reduces survival in hyperglycemic mice.Diabetes alters activation and repression of pro- and anti-inflammatory signaling pathways in the vasculature.Diabetes mellitus and glucose as predictors of mortality in primary coronary percutaneous interventionLeft ventricular structure and function in prediabetic adults: Relationship with insulin resistance.Metabolic Syndrome is Associated With Higher Wall Motion Score and Larger Infarct Size After Acute Myocardial Infarction.Admission glucose and risk of early death in non-diabetic patients with ST-segment elevation myocardial infarction: a meta-analysis.Acute hyperglycaemia: a 'new' risk factor during myocardial infarction.Impact of Admission Glucose on Non-Diabetic Patients with ST-Segment Elevation Myocardial Infarction Treated with Percutaneous Coronary Intervention: A Meta-AnalysisHyperglycemia in the hospital setting: the case for improved control among non-diabetics.Standardized Glycemic Management with a Computerized Workflow and Decision Support System for Hospitalized Patients with Type 2 Diabetes on Different WardsAdmission hyperglycemia and acute myocardial infarction: outcomes and potential therapies for diabetics and nondiabetics.Protective effect of glucagon-like peptide-1 agents on reperfusion injury for acute myocardial infarction: a meta-analysis of randomized controlled trials.The acute reperfusion management of STEMI in patients with impaired glucose tolerance and type 2 diabetes.Utility of Cardiac Magnetic Resonance to assess association between admission hyperglycemia and myocardial damage in patients with reperfused ST-segment elevation myocardial infarction.Acute insulin resistance in myocardial ischemia: causes and consequences.Hyperglycemia and outcome after myocardial infarction and cardiac surgery: so what?Glucose-insulin-potassium techniques in cardiac surgery: historical overview and future perspectives.Insulin infusion therapy for myocardial infarction.Hyperglycemia and perioperative glucose management.Interleukin-18 is a strong predictor of cardiovascular events in elderly men with the metabolic syndrome: synergistic effect of inflammation and hyperglycemia.Glucose control during acute myocardial infarction.Elective percutaneous coronary intervention: the relationship between preprocedural blood glucose levels and periprocedural myocardial injury.Myocardial lipid accumulation in patients with pressure-overloaded heart and metabolic syndrome.Admission Glucose and In-hospital Mortality after Acute Myocardial Infarction in Patients with or without Diabetes: A Cross-sectional StudyMeta-analysis of admission hyperglycaemia in acute myocardial infarction patients treated with primary angioplasty: a cause or a marker of mortality?Naringin inhibits ROS-activated MAPK pathway in high glucose-induced injuries in H9c2 cardiac cells.Prevention of Surgical Site Infection in Spine Surgery.Hypoglycemia in Non-diabetics During Development of Acute Coronary Ischemia.Hyperglycaemia at admission in acute coronary syndrome patients: prognostic value in diabetics and non-diabetics.Hyperosmotic stress enhances cytokine production and decreases phagocytosis in vitro.A no-reflow prediction model in patients with ST-elevation acute myocardial infarction and primary drug-eluting stenting.The glucose dysmetabolism in the acute phase of non-diabetic ST-elevation myocardial infarction: from insulin resistance to hyperglycemia.Prevalence, incidence, and clinical resolution of insulin resistance in critically ill patients: an observational study.
P2860
Q24602948-BF95D771-54F1-47FC-902C-CA7409D730D0Q30279293-C794A194-584F-4FAE-A86F-47C8E102798BQ30415665-A156DFC0-2AD5-47AF-9ECE-CACB0D658A1DQ30436954-D64E79FC-D8C2-4B67-AC1B-9FBBEBB680D8Q33321943-5F6AAA49-8305-410D-9596-D85DB2179348Q33653141-190A5B32-C541-4F3B-BDDB-79BC439F0030Q33749968-6103044B-0C9A-4661-99D7-3087E661C6C0Q34100286-215B13BB-8A93-4D8C-91B0-C88B0D7190D2Q34350546-7B25D946-F99B-414E-B455-00D0CAD05128Q34387856-90ADAB50-80F1-4716-9E1D-7FE81DF26D39Q35060414-BCC2B6A0-EE6D-4785-B42C-C8C72CE4E93AQ35149077-3DA6515B-9C94-4990-93F9-042740F61411Q35633803-515CC312-BA56-4196-ABB7-32A856578004Q35993115-476CEB36-E64E-408A-96A1-62F940A380FDQ36001476-23ACBBA0-6094-459D-8DB7-0783AAD73AE9Q36035243-37731EF3-63AB-4BF5-AB21-640220A09891Q36074125-291651E1-564C-4AFA-A31C-282B0608BA78Q36102103-1B41EAEF-AFB3-4DBE-A6EB-39413BCD93C9Q36305825-B2AD53C0-2729-4D2F-93F7-CCD06521D640Q36333927-87FBAFAE-E88E-42A3-BD0B-3EC55804D325Q36462622-BC818824-2A91-40C4-80D7-613DD5B536CEQ36588698-C9F576AF-1E93-4440-9766-1AF9A629A9E6Q36588701-8297C307-1C4F-43B0-AEC7-DF2D8A8322E4Q36588704-5C236F2E-83D6-4E76-95DA-38C8B6DE2D21Q36675392-6A18A158-60F8-4B2B-B05F-10420613B98EQ36810316-00C14191-F55C-47C8-B93C-2DDF5A1DB1BFQ37105230-403544E2-B3CF-4BCA-AFA0-964E101EE17CQ37134518-93ED2E80-7124-4DE7-950D-2FC9AB9D6AA1Q37197718-1970AB9D-246D-4D87-B15B-652E5F4871C2Q37382176-C76145CF-981D-473D-952D-FB05DD4D1299Q37738294-8144B6D5-0CD3-474F-8B4D-415D5D1B67B0Q38929573-BC8E363B-2273-405F-B3CF-DC7649D1212FQ39080574-157E0CFB-5EEE-43A9-953C-D9172B0EB663Q39205008-3A7D3926-CC72-470F-911C-32711EDA2DF6Q40920321-073EF4A4-213E-4A87-A218-00B87AFE3A57Q43181353-4FCBC2B4-E1E1-4239-A4CE-6248953998B2Q43249050-FB29FF57-8B59-4681-938A-CB87FBA7A4D4Q44127712-1E8ED439-098A-450D-8C27-BFCB50A21FA4Q45335331-BA699FB9-14EB-4867-BE41-48289F35C385Q46621763-9F0A295C-40A6-4C16-BE46-2D92B9E57158
P2860
Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Effects of stress hyperglycemi ...... in functional cardiac outcome.
@ast
Effects of stress hyperglycemi ...... in functional cardiac outcome.
@en
type
label
Effects of stress hyperglycemi ...... in functional cardiac outcome.
@ast
Effects of stress hyperglycemi ...... in functional cardiac outcome.
@en
prefLabel
Effects of stress hyperglycemi ...... in functional cardiac outcome.
@ast
Effects of stress hyperglycemi ...... in functional cardiac outcome.
@en
P2093
P50
P1433
P1476
Effects of stress hyperglycemi ...... in functional cardiac outcome
@en
P2093
Ausilia Sellitto
Federico Cacciapuoti
Francesco Nappo
Giacomo Lucivero
Katherine Esposito
Mario Siniscalchi
Mario Verza
Michele Portoghese
Nicola Mininni
Raffaele Marfella
P304
P356
10.2337/DIACARE.26.11.3129
P407
P577
2003-11-01T00:00:00Z